Trial for People With Established Type 2 Diabetes During Ramadan
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Dual therapy with metformin and Liraglutide is more effective at helping people with
established Type 2 Diabetes Mellitus (T2DM) observing Ramadan achieve a triple composite
endpoint of weight reduction and/or maintenance and improved HaemaglobinA1c (HbA1c) and no
severe hypoglycaemic events.
Phase:
Phase 4
Details
Lead Sponsor:
University of Leicester
Collaborators:
University Hospital Birmingham University Hospitals, Leicester